NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $246,000 | -13.7% | 2,909 | -16.6% | 0.02% | -21.1% |
| Q3 2021 | $285,000 | -8.1% | 3,487 | +2.6% | 0.02% | -9.5% |
| Q2 2021 | $310,000 | +16.5% | 3,399 | +9.2% | 0.02% | +10.5% |
| Q1 2021 | $266,000 | +13.2% | 3,113 | +25.0% | 0.02% | -9.5% |
| Q4 2020 | $235,000 | +487.5% | 2,490 | +414.5% | 0.02% | +250.0% |
| Q1 2020 | $40,000 | -13.0% | 484 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $46,000 | -47.7% | 484 | -52.0% | 0.01% | -53.8% |
| Q3 2019 | $88,000 | +72.5% | 1,009 | +80.2% | 0.01% | +62.5% |
| Q2 2019 | $51,000 | -5.6% | 560 | 0.0% | 0.01% | -11.1% |
| Q1 2019 | $54,000 | +12.5% | 560 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $48,000 | -29.4% | 560 | -29.0% | 0.01% | -25.0% |
| Q3 2018 | $68,000 | +13.3% | 789 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $60,000 | -6.2% | 789 | 0.0% | 0.01% | -14.3% |
| Q1 2018 | $64,000 | -50.8% | 789 | -49.1% | 0.01% | -57.6% |
| Q4 2017 | $130,000 | +22.6% | 1,551 | +25.5% | 0.03% | +6.5% |
| Q3 2017 | $106,000 | – | 1,236 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |